Addressing sexual minority gaps in cervical and breast cancer screening

A published provides evidence for the existence of screening disparities for breast and cervical cancer in SOGI minority groups. This study analysed BRFSS data from 2018–2022, and included participants who had data on sexual orientation and gender identity, and who met the eligibility criteria for breast and cervical cancer screening. Gender identity minority (GIM) individuals had 76% lower and 45% lower adherence to breast and cervical cancer screening, respectively, compared to cisgender respondents. Credit: Chinnapong via Shutterstock.com. According to the US Centers for Disease Control and Prevention (CDC), over 43,000 females and 4,000 females died from breast cancer and cervical…

Source: Clinical Trials Arena